|
| |
| | | 65695 | | 05.07.2016 | | AstraZeneca AG | | | | | | | | | | | | | 08.03. | | | | 08.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Synagis 50 mg/0.5 ml | Injektionslösung | Injection solution (Palivizumab 50mg / 0.5ml) | J06BD01 | CI | | 02 | Synagis 100 mg/1 ml | Injektionslösung | Injection solution (Palivizumab 100 mg/ml) | J06BD01 | CI |
|
|
|
